Higher expression of Crk in cancer tissues has been reported to contribute to poor prognosis and lower survival of patients with oral squamous cell carcinoma [53], glioblastoma [50], lung cancer [64], gastric cancer [68,69], and colorectal cancer [40]. This evidence concerns the gene CRK and colorectal cancer.